Literature DB >> 28830580

Antibiotic-associated Manipulation of the Gut Microbiota and Phenotypic Restoration in NOD Mice.

James R Fahey1, Bonnie L Lyons2, Haiyan L Olekszak2, Anthony J Mourino2, Jeremy J Ratiu3, Jeremy J Racine3, Harold D Chapman3, David V Serreze3, Dina L Baker4, N Ken Hendrix4.   

Abstract

Segmented filamentous bacterium (SFB) a gram-positive, anaerobic, and intestinal commensal organism directly influences the development of Th17 helper cells in the small intestine of mice. In NOD mice, SFB colonization interferes with the development of type 1 diabetes (T1D), a T-cell-mediated autoimmune disease, suggesting that SFB may influence Th17 cells to inhibit Th1 populations associated with the anti-β-cell immune response. This effect is a serious concern for investigators who use NOD mice for diabetes research because the expected incidence of disease decreases markedly when they are colonized by SFB. A room housing mice for T1D studies at The Jackson Laboratory was determined by fecal PCR testing to have widespread SFB colonization of multiple NOD strains after a steady decline in the incidence of T1D was noted. Rederivation of all NOD-related mouse strains was not feasible; therefore an alternative treatment using antibiotics to eliminate SFB from colonized mice was undertaken. After antibiotic treatment, soiled bedding from NOD mouse strains housed in SFB-free high-health-status production barrier rooms was used to reintroduce the gastrointestinal microbiota. Over the past 16 mo since treating the mice and disinfecting the mouse room, regular PCR testing has shown that no additional SFB colonization of mice has occurred, and the expected incidence of T1D has been reestablished in the offspring of treated mice.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28830580      PMCID: PMC5557205     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  37 in total

1.  Evidence for a complex life cycle and endospore formation in the attached, filamentous, segmented bacterium from murine ileum.

Authors:  D G Chase; S L Erlandsen
Journal:  J Bacteriol       Date:  1976-07       Impact factor: 3.490

2.  IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes.

Authors:  Julie Joseph; Stefan Bittner; Fabian M P Kaiser; Heinz Wiendl; Stephan Kissler
Journal:  J Immunol       Date:  2011-11-23       Impact factor: 5.422

3.  Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.

Authors:  L Hermitte; B Vialettes; P Naquet; C Atlan; M J Payan; P Vague
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

4.  Antibiotic-mediated gut microbiome perturbation accelerates development of type 1 diabetes in mice.

Authors:  Alexandra E Livanos; Thomas U Greiner; Pajau Vangay; Wimal Pathmasiri; Delisha Stewart; Susan McRitchie; Huilin Li; Jennifer Chung; Jiho Sohn; Sara Kim; Zhan Gao; Cecily Barber; Joanne Kim; Sandy Ng; Arlin B Rogers; Susan Sumner; Xue-Song Zhang; Ken Cadwell; Dan Knights; Alexander Alekseyenko; Fredrik Bäckhed; Martin J Blaser
Journal:  Nat Microbiol       Date:  2016-08-22       Impact factor: 17.745

5.  Comparison of 16S rRNA sequences of segmented filamentous bacteria isolated from mice, rats, and chickens and proposal of "Candidatus Arthromitus".

Authors:  J Snel; P P Heinen; H J Blok; R J Carman; A J Duncan; P C Allen; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1995-10

6.  Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.

Authors:  Ricardo Valladares; Dhyana Sankar; Nan Li; Emily Williams; Kin-Kwan Lai; Asmaa Sayed Abdelgeliel; Claudio F Gonzalez; Clive H Wasserfall; Joseph Larkin; Desmond Schatz; Mark A Atkinson; Eric W Triplett; Josef Neu; Graciela L Lorca
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

7.  Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice.

Authors:  H L Klaasen; P J Van der Heijden; W Stok; F G Poelma; J P Koopman; M E Van den Brink; M H Bakker; W M Eling; A C Beynen
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Growth and host interaction of mouse segmented filamentous bacteria in vitro.

Authors:  Pamela Schnupf; Valérie Gaboriau-Routhiau; Marine Gros; Robin Friedman; Maryse Moya-Nilges; Giulia Nigro; Nadine Cerf-Bensussan; Philippe J Sansonetti
Journal:  Nature       Date:  2015-01-19       Impact factor: 49.962

9.  NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes.

Authors:  T Z DeSantis; P Hugenholtz; K Keller; E L Brodie; N Larsen; Y M Piceno; R Phan; G L Andersen
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

10.  Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice.

Authors:  Kyle J Wolf; Joseph G Daft; Scott M Tanner; Riley Hartmann; Ehsan Khafipour; Robin G Lorenz
Journal:  J Histochem Cytochem       Date:  2014-01-22       Impact factor: 2.479

View more
  3 in total

Review 1.  Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes.

Authors:  Shubhabrata Majumdar; Yong Lin; Matthew L Bettini
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

2.  Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.

Authors:  Suzana Stanisavljević; Miroslav Dinić; Bojan Jevtić; Neda Đedović; Miljana Momčilović; Jelena Đokić; Nataša Golić; Marija Mostarica Stojković; Đorđe Miljković
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

Review 3.  The microbiome and rodent models of immune mediated diseases.

Authors:  Axel Kornerup Hansen; Camilla Hartmann Friis Hansen
Journal:  Mamm Genome       Date:  2021-04-01       Impact factor: 2.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.